Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Joint ( (JYNT) ).
On April 20, 2026, Joint agreed to sell the assets of, and grant franchise rights to, 45 company-owned or managed clinics in Southern California to Elite Chiro Group for an aggregate purchase price of $2.3 million, subject to adjustments. The deal includes prorated franchise fees under 45 new franchise agreements and non-exclusive development rights for 10 additional clinics, with $150,000 paid as a non-refundable exclusivity down payment and the remainder held in escrow, while each clinic closing depends on lease assignments and customary closing conditions, signaling a strategic shift toward franchising in this key market.
The structure of the transaction, including escrow allocations per clinic and standard covenants, representations, and warranties, is typical for deals of this size and complexity. By converting a large cluster of company-owned or managed clinics into franchised locations and granting regional development rights, Joint appears to be accelerating an asset-light growth strategy that may reduce operating risk while preserving recurring franchise revenue potential in Southern California.
The most recent analyst rating on (JYNT) stock is a Hold with a $8.55 price target. To see the full list of analyst forecasts on Joint stock, see the JYNT Stock Forecast page.
Spark’s Take on JYNT Stock
According to Spark, TipRanks’ AI Analyst, JYNT is a Neutral.
The score is driven primarily by mid-range fundamentals: improved net profitability and conservative leverage are outweighed by volatile revenue, inconsistent operating profitability, and a sharp 2025 drop in operating/free cash flow. Earnings-call guidance and the refranchising plan provide a meaningful positive offset, while bearish technicals and a high P/E with no dividend keep the overall rating constrained.
To see Spark’s full report on JYNT stock, click here.
More about Joint
Joint operates a network of chiropractic clinics, focusing on company-owned and managed locations that can be transitioned to a franchise model. The company generates revenue from clinic operations, franchise fees, and development rights, with a particular market focus in regions such as Southern California, where it has built a sizable clinic footprint.
Average Trading Volume: 61,175
Technical Sentiment Signal: Strong Sell
Current Market Cap: $126M
See more insights into JYNT stock on TipRanks’ Stock Analysis page.